2019

1. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study

   American Journal of Psychiatry, Vol. 176, Núm. 6, pp. 428-438

2. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients with Treatment-Resistant Depression: A Randomized Clinical Trial

   JAMA Psychiatry, Vol. 76, Núm. 9, pp. 893-903